Daily blood pressure profile and blood–brain barrier permeability in patients with cerebral small vessel disease

Background: Cerebral small vessel disease (CSVD) plays an important role in cognitive impairment (CI), stroke, disability and death. Arterial hypertension (AH) is the main risk factor for CSVD. The use of antihypertensive therapy (AHT) has not resulted in the expected decrease in CSVD complications, which may be related to the underestimation of significance of daily blood pressure profile for blood–brain barrier (BBB) permeability. Methods53 patients with CSVD of varying severity (mean age 60.086.8 years, 69.8% women, subjects with long-standing AH vs. normotensive subjects – 84.8% vs. 15.2%) and 17 healthy volunteers underwent ambulatory blood pressure monitoring (ABPM) and MRI, including T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for assessing BBB permeability. ResultsMost of ABPM parameters in CSVD patients did not differ from controls, but were associated with the severity of white matter hyperintensity (WMH) and the total CSVD score. BBB permeability in normal-appearing white matter (NAWM) and grey matter (GM) was significantly higher in CSVD patients, and the severity of BBB permeability remained similar in patients with different stages of WMH. Among BBB permeability parameters, the area under the curve, corresponding to an increase in the contrast transit time in NAWM, had the greatest number of correlations with deviations of ABPM parameters. ConclusionBBB permeability in CSVD is a universal mechanism of NAWM and GM damage associated with a slight increase in ABPM parameters. It is obvious that the treatment of AH in patients with not severe WMH should be more aggressive and carried out under the control of ABPM.